Suggestions
David Allan
Principal at Cresswell Advisors
David G P Allan is the Principal at CRESSWELL ADVISORS INC, a position he has held since January 1995.1 He is a prominent figure in the life sciences and biotech industry, with extensive experience in advisory and consultancy roles for development-stage companies.1
Allan has received several notable awards for his contributions to the field:
- The 2017 Julia Levy Award from the Chemical Institute of Canada (CIC)/Society of Chemical Industry (SCI)12
- The 2016 Life Sciences Ontario Leadership Award12
- The 2012 Gold Leaf Award from BIOTECanada12
In addition to his role at Cresswell Advisors, Allan holds several other positions:
- Managing Director and Board Member at eQcell Inc., a clinical-stage regenerative medicine company, since 20211
- Advisory Board member at Haygain Ltd, a leading producer of equine health devices1
- Advisory Board member at Inteligex Inc., developing stem cell therapies for spinal cord injuries and CNS diseases1
Allan has a significant background in finance and the biotech industry. He was the founding and sunset chair of YM BioSciences Inc., serving as CEO from 1998 to 2011.23 He also founded the first biotech-specific investment banking team in Canada in 1992.2
Throughout his career, Allan has held leadership positions in various companies, including:
- Founding Chairman of Formation Biologics (acquired by Bristol Myers Squibb in 2020)23
- Executive Chairman of Stem Cell Therapeutics (now Trillium Therapeutics, acquired by Pfizer in 2021)23
Allan has also served on several committees and boards, including the Awards Selection Committee of Canada's Network of Centers of Excellence, the Multidisciplinary Assessment Committees of the Canada Foundation for Innovation, and as a former Governor of the Toronto Stock Exchange.3


